Tumor-intrinsic interferon signaling drives pancreatic cancer resistance to tumor mucin1-targeted CAR T cell therapy

Pancreatic cancer (PC) remains one of the most challenging cancers and has the worst prognosis. Tumor-associated MUC1 (tMUC1) is overexpressed and aberrantly glycosylated in over 80% of human pancreatic ductal adenocarcinoma (PDA). Chimeric antigen receptor (CAR) engineered T cells are an emerging c...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ru Zhou, Rebecca Mayberry, Taina Firmin, Alexa Sanders, Cory Brouwer, John Maher, Pinku Mukherjee
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2025-08-01
Edice:	Frontiers in Immunology
Témata:	CAR T cells MUC1 PDA resistance interferon signaling
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1618415/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!